Zeffix
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zeffix, covering 2025-06-03 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Zeffix (lamivudine) — GlaxoSmithKline Trading Services Limited